Lilly said it plans to start Phase 3 trials on the combo regimen adding its amylin drug eloralintide to tirzepatide at the end of the year.
Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
Trending
- Deal alert: Get $1,000 in onboard credit on a Tahiti cruise with this amazing offer
- ‘Some young juice’: What makes Maple Leafs’ Cowan driven to win
- Steady Stolarz leads new-look Maple Leafs to first victory
- ‘Two good wins for us’: Lombard Jr. reflects on Yankees’ Wild Card wins
- Wings’ Ogunbowale explodes in OT to set WNBA playoff scoring record
- Padres complete two-game sweep of Cubs, book spot in NLDS
- MacKinnon drops mitts with Clarke for first fight in four years
- MacKinnon has two goals, rare fight in Avalanche’s victory over Kings in opener
